Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Blood Glucose
100%
Peripheral Electrical Stimulation
100%
Randomized Crossover
100%
Glucose Level
75%
Active Period
50%
Stimulation Treatment
50%
Hepatic Glucose Production
50%
Insulin
25%
Glucose Control
25%
Drug Development
25%
Clinical Significance
25%
Type 2 Diabetic Patients
25%
Adverse Events
25%
Laboratory Evaluation
25%
Randomized Trial
25%
Lower Extremity
25%
Tolerability
25%
Antidiabetic Drugs
25%
Hypoglycemic Episodes
25%
HPA Axis
25%
Crossover Design
25%
Blood Glucose Control
25%
Glucose Homeostasis
25%
Control Period
25%
Potential Side Effects
25%
Plasma Glucose
25%
Glucose Utilization
25%
Burst Mode
25%
Hepatic Insulin Sensitivity
25%
Nocturnal Glucose
25%
Pre-meal
25%
Glucose Meter
25%
Serum Cortisol
25%
Meter Reading
25%
Continuous Glucose
25%
Glucose-lowering Drugs
25%
Medicine and Dentistry
Electrostimulation
100%
Blood Glucose
100%
Maturity Onset Diabetes of the Young
100%
Antidiabetic Agent
50%
Type 2 Diabetes
50%
Gluconeogenesis
50%
Clinical Study
25%
Adverse Event
25%
Side Effect
25%
Patient with Type 2 Diabetes
25%
Clinical Significance
25%
Meal
25%
Hydrocortisone
25%
Insulin Sensitivity
25%
Glucose Homeostasis
25%
Glucose Utilization
25%
Blood Glucose Monitoring
25%
Hypothalamic-Pituitary-Adrenal Axis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Antidiabetic Agent
100%
Side Effect
50%
Drug Development
50%
Hydrocortisone
50%
Adverse Event
50%
Tolerability
50%
Preclinical Study
50%
Neuroscience
Gluconeogenesis
100%
Cortisol
50%
Hypothalamic-Pituitary-Adrenal Axis
50%
Blood Glucose Monitoring
50%